NCT03379805

Brief Summary

The lymphatics regulate the interstitial fluid by removing excessive fluid. It represents an extremely important step in the prevention of edema. The Fontan-Kreutzer procedure has revolutionized the treatment of univentricular hearts. However, it is associated with severe complications such as protein-losing enteropathy (PLE) and peripheral edema that may involve the lymphatic circulation. Our hypothesis is that patients with a univentricular circulation have a reduced functionality of the lymphatic vasculature, which predisposes them to developing complications such as edema and PLE. The functional state of lymphatics is investigated using near infrared fluorescence imaging, NIRF. The anatomy is described using non-contrast MRI and the capillary filtration rate is measured using plethysmography.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2014

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 25, 2014

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 20, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

December 20, 2017

Status Verified

December 1, 2017

Enrollment Period

3.2 years

First QC Date

December 12, 2017

Last Update Submit

December 19, 2017

Conditions

Outcome Measures

Primary Outcomes (5)

  • Pumping pressure

    Occlusion of lymphatic flow by inflating a cuff (Hokanson E20 Rapid cuff inflator, Hokanson AG101 air source) to 70mmHg and then reducing the pressure with 5mmHg each 5th minute. The highest pressure under which the fluorescent dye is able to cross the inflatable cuff is labelled Ppump.

    1 hour

  • Contraction Frequency

    Contraction frequency in vessels in the main drainage pathway of the legs (ventromedial bundle) as well as vessels draining the area behind the medial malleolus.

    6 min

  • Refill time

    The time it takes for a 10 cm long vessel to refill after emptying the vessel with massage

    20 min

  • Velocity

    The velocity measured in cm/s for a packet of lymph moving from one region of interest (ROI) to another through atlas a 5 cm straight vessel

    6 min

  • Capillary Filtration Rate

    A 5-step 20-min venous congestion protocol will be used to measure capillary filtration. The capillary filtration rate (µl·100 ml-1 ·min-1 ) is measured as the slope of the time-volume change (%) curve at steady state at the end of each pressure phase.

    25 min

Study Arms (2)

Fontan-Kreutzer operated patients

Patients with a Fontan-Kreutzer circulation. No interventions are done. (The intervention is the operation done 15-20 years ago)

Diagnostic Test: Near Infrared Fluorescence ImagingDiagnostic Test: Non-contrast MRIDiagnostic Test: Strain Gauge Plethysmography

Healthy Control subjects

Age, gender and weight matched control subjects

Diagnostic Test: Near Infrared Fluorescence ImagingDiagnostic Test: Non-contrast MRIDiagnostic Test: Strain Gauge Plethysmography

Interventions

The functional state of lymphatics is investigated using near infrared fluorescence imaging, NIRF.

Also known as: Strain-Gauge Plethysmography
Fontan-Kreutzer operated patientsHealthy Control subjects
Non-contrast MRIDIAGNOSTIC_TEST

The anatomy is described using non-contrast MRI.

Fontan-Kreutzer operated patientsHealthy Control subjects

The capillary filtration rate is measured using plethysmography

Fontan-Kreutzer operated patientsHealthy Control subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients born with an univentricular heart, who surgically is corrected with a Fontan-Kreutzer Circulation

You may qualify if:

  • Fontan-Kreutzer circulation

You may not qualify if:

  • BMI\>30,
  • Age\<18
  • Mental illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Mohanakumar S, Telinius N, Kelly B, Lauridsen H, Boedtkjer D, Pedersen M, de Leval M, Hjortdal V. Morphology and Function of the Lymphatic Vasculature in Patients With a Fontan Circulation. Circ Cardiovasc Imaging. 2019 Apr;12(4):e008074. doi: 10.1161/CIRCIMAGING.118.008074.

MeSH Terms

Conditions

Lymphatic AbnormalitiesLymphedemaUniventricular Heart

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart Diseases

Study Officials

  • Vibeke E Hjortdal, MD, PhD, Dr.Med

    Aarhus University Hospital, Department of Cardiothoracic and Vascular Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 20, 2017

Study Start

April 25, 2014

Primary Completion

June 20, 2017

Study Completion

August 31, 2018

Last Updated

December 20, 2017

Record last verified: 2017-12